398 related articles for article (PubMed ID: 27000837)
1. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.
Chanu SI; Sarkar S
Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of dMyc mitigates Tau
Pragati ; Chanu SI; Sarkar S
Neurosci Lett; 2020 Jan; 715():134622. PubMed ID: 31715291
[TBL] [Abstract][Full Text] [Related]
3. Targeted downregulation of dMyc restricts neurofibrillary tangles mediated pathogenesis of human neuronal tauopathies in Drosophila.
Chanu SI; Sarkar S
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2111-2119. PubMed ID: 28529046
[TBL] [Abstract][Full Text] [Related]
4. Shaggy functions downstream of dMyc and their concurrent downregulation confers additive rescue against tau toxicity in Drosophila.
Pragati ; Sarkar S
Biofactors; 2021 May; 47(3):461-477. PubMed ID: 33651466
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of glob1 mitigates human tau mediated neurotoxicity by restricting heterochromatin loss and elevating the autophagic response in drosophila.
Nisha ; Sarkar S
Mol Biol Rep; 2022 Jul; 49(7):6581-6590. PubMed ID: 35633418
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of glob1 suppresses pathogenesis of human neuronal tauopathies in Drosophila by regulating tau phosphorylation and ROS generation.
Nisha ; Sarkar S
Neurochem Int; 2021 Jun; 146():105040. PubMed ID: 33865914
[TBL] [Abstract][Full Text] [Related]
7. NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.
Ali YO; Ruan K; Zhai RG
Hum Mol Genet; 2012 Jan; 21(2):237-50. PubMed ID: 21965302
[TBL] [Abstract][Full Text] [Related]
8. Targeted Downregulation of
Park SY; Seo J; Chun YS
J Korean Med Sci; 2019 Aug; 34(33):e225. PubMed ID: 31436053
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.
Ubhi KK; Shaibah H; Newman TA; Shepherd D; Mudher A
Invert Neurosci; 2007 Sep; 7(3):165-71. PubMed ID: 17636367
[TBL] [Abstract][Full Text] [Related]
11. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
12. Tau promotes neurodegeneration through global chromatin relaxation.
Frost B; Hemberg M; Lewis J; Feany MB
Nat Neurosci; 2014 Mar; 17(3):357-66. PubMed ID: 24464041
[TBL] [Abstract][Full Text] [Related]
13. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
[TBL] [Abstract][Full Text] [Related]
14. Studying tauopathies in Drosophila: A fruitful model.
Sun M; Chen L
Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
16. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
17. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
18. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in
Mao CX; Wen X; Jin S; Zhang YQ
Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043
[TBL] [Abstract][Full Text] [Related]
19. TBK1 interacts with tau and enhances neurodegeneration in tauopathy.
Abreha MH; Ojelade S; Dammer EB; McEachin ZT; Duong DM; Gearing M; Bassell GJ; Lah JJ; Levey AI; Shulman JM; Seyfried NT
J Biol Chem; 2021; 296():100760. PubMed ID: 33965374
[TBL] [Abstract][Full Text] [Related]
20. Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.
Frost B; Bardai FH; Feany MB
Curr Biol; 2016 Jan; 26(1):129-36. PubMed ID: 26725200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
